Arterex, a global medical device developer and contract manufacturer, has completed its acquisition of Phoenix S.r.l. (Phoenix), a European developer and manufacturer of medical devices with global sales. Financial terms of the transaction were not disclosed.

Located near Modena, Italy, Phoenix develops, assembles, and packages medical devices in a roughly 37,000-square-foot manufacturing space and four ISO 8 cleanrooms. The company is ISO 13485:2016 certified and operates in compliance with the European Union’s MDR.

“The acquisition of Phoenix is a strategic step for Arterex, allowing us to expand our medical device development and finished device assembly and packaging capabilities to Europe,” said Jeffery Goble, Arterex CEO. “With a deep commitment to innovation, quality, and customer support, Phoenix will strengthen our position as a leading, global provider of specialized and multi-capability manufacturing solutions.” 

The acquisition marks the next chapter in Arterex’s journey to provide customers in North America and Europe with comprehensive services, including design, development, engineering, compounding, extrusion, injection molding, tooling, and mold builds, as well as advanced assembly and packaging capabilities.

“We are excited to join the Arterex group of companies, given our strategically aligned missions to provide leading-edge medical device solutions,” said Marco Bulgarelli, co-CEO at Phoenix. “Arterex is a trusted leader in the medical device manufacturing sector and together we will be well-positioned to find creative and effective solutions for our clients’ needs.”

Arterex operates through nine state-of-the-art manufacturing facilities across three continents with over 1,250 employees and is a global leader in diversified manufacturing solutions to the medical device and life sciences industries.